{
  "citations": [
    {
      "id": 7283333,
      "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
      "_sameAs": "https://www.ncbi.nlm.nih.gov/pubmed/21412232",
      "authors": [
        "Swen J J",
        "Nijenhuis M",
        "de Boer A",
        "Grandia L",
        "Maitland-van der Zee A H",
        "Mulder H",
        "Rongen G A P J M",
        "van Schaik R H N",
        "Schalekamp T",
        "Touw D J",
        "van der Weide J",
        "Wilffert B",
        "Deneer V H M",
        "Guchelaar H-J"
      ],
      "crossReferences": [
        {
          "id": 769250885,
          "resource": "PubMed",
          "resourceId": "21412232",
          "_url": "https://www.ncbi.nlm.nih.gov/pubmed/21412232",
          "version": 0
        },
        {
          "id": 1449247827,
          "resource": "DOI",
          "resourceId": "10.1038/clpt.2011.34",
          "_url": "http://dx.doi.org/10.1038%2Fclpt.2011.34",
          "version": 0
        }
      ],
      "hasKeyword": true,
      "journal": "Clinical pharmacology and therapeutics",
      "meshDiseases": [],
      "meshTerms": [
        "Animals",
        "Aryl Hydrocarbon Hydroxylases",
        "Cytochrome P-450 CYP2C9",
        "Drug Administration Schedule",
        "Drug-Related Side Effects and Adverse Reactions",
        "Humans",
        "Pharmaceutical Preparations",
        "Pharmacogenetics",
        "Practice Guidelines as Topic"
      ],
      "month": 5,
      "nonHuman": false,
      "objCls": "Literature",
      "page": "662-73",
      "pediatric": false,
      "pgkbPublication": false,
      "pubDate": "2011-05-01T00:00:00-07:00",
      "summary": "Currently, there are very few guidelines linking the results of pharmacogenetic tests to specific therapeutic recommendations. Therefore, the Royal Dutch Association for the Advancement of Pharmacy established the Pharmacogenetics Working Group with the objective of developing pharmacogenetics-based therapeutic (dose) recommendations. After systematic review of the literature, recommendations were developed for 53 drugs associated with genes coding for CYP2D6, CYP2C19, CYP2C9, thiopurine-S-methyltransferase (TPMT), dihydropyrimidine dehydrogenase (DPD), vitamin K epoxide reductase (VKORC1), uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1), HLA-B44, HLA-B*5701, CYP3A5, and factor V Leiden (FVL).",
      "terms": [],
      "version": 2,
      "volume": "89",
      "year": 2011
    }
  ],
  "guideline": {
    "objCls": "Guideline Annotation",
    "id": "PA166104968",
    "name": "Annotation of DPWG Guideline for venlafaxine and CYP2D6",
    "alternateDrugAvailable": false,
    "cancerGenome": false,
    "crossReferences": [],
    "dosingInformation": false,
    "guidelineGenes": [
      {
        "id": 1451421198,
        "alleles": [
          {
            "id": 1451421220,
            "_label": "*1",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816576",
              "symbol": "CYP2D6*1",
              "name": "*1",
              "version": 43
            },
            "version": 0
          },
          {
            "id": 1451421254,
            "_label": "*1x2",
            "function": {
              "id": 1451309754,
              "description": "CYP2D6 function",
              "parents": [],
              "resource": "Allele Function",
              "term": "Increased function (AV 2)",
              "termId": "alleleFunction:1451309754",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228081",
              "symbol": "CYP2D6*1x2",
              "name": "*1x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451421255,
            "_label": "*1x≥3",
            "function": {
              "id": 1451309780,
              "description": "CYP2D6 function",
              "parents": [],
              "resource": "Allele Function",
              "term": "Increased function (AV ≥3)",
              "termId": "alleleFunction:1451309780",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228141",
              "symbol": "CYP2D6*1x≥3",
              "name": "*1x≥3",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451421221,
            "_label": "*2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816577",
              "symbol": "CYP2D6*2",
              "name": "*2",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451421256,
            "_label": "*2x2",
            "function": {
              "id": 1451309754,
              "description": "CYP2D6 function",
              "parents": [],
              "resource": "Allele Function",
              "term": "Increased function (AV 2)",
              "termId": "alleleFunction:1451309754",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228161",
              "symbol": "CYP2D6*2x2",
              "name": "*2x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451421257,
            "_label": "*2x≥3",
            "function": {
              "id": 1451309780,
              "description": "CYP2D6 function",
              "parents": [],
              "resource": "Allele Function",
              "term": "Increased function (AV ≥3)",
              "termId": "alleleFunction:1451309780",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228162",
              "symbol": "CYP2D6*2x≥3",
              "name": "*2x≥3",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451421222,
            "_label": "*3",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816578",
              "symbol": "CYP2D6*3",
              "name": "*3",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451421258,
            "_label": "*3x2",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228163",
              "symbol": "CYP2D6*3x2",
              "name": "*3x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451421223,
            "_label": "*4",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816579",
              "symbol": "CYP2D6*4",
              "name": "*4",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451421262,
            "_label": "*4x2",
            "allele": "*4x2",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451421224,
            "_label": "*5",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165948092",
              "symbol": "CYP2D6*5",
              "name": "*5",
              "version": 41
            },
            "version": 0
          },
          {
            "id": 1451421225,
            "_label": "*6",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816581",
              "symbol": "CYP2D6*6",
              "name": "*6",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451421259,
            "_label": "*6x2",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228165",
              "symbol": "CYP2D6*6x2",
              "name": "*6x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451421226,
            "_label": "*7",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971559",
              "symbol": "CYP2D6*7",
              "name": "*7",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421227,
            "_label": "*8",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971560",
              "symbol": "CYP2D6*8",
              "name": "*8",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421228,
            "_label": "*9",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165948317",
              "symbol": "CYP2D6*9",
              "name": "*9",
              "version": 41
            },
            "version": 0
          },
          {
            "id": 1451421229,
            "_label": "*9x2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166123309",
              "symbol": "CYP2D6*9x2",
              "name": "*9x2",
              "version": 21
            },
            "version": 0
          },
          {
            "id": 1451421263,
            "_label": "*10",
            "allele": "*10",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451421199,
            "_label": "*10x2",
            "allele": "*10x2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451421230,
            "_label": "*11",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971564",
              "symbol": "CYP2D6*11",
              "name": "*11",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421231,
            "_label": "*12",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971565",
              "symbol": "CYP2D6*12",
              "name": "*12",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421232,
            "_label": "*13",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165988481",
              "symbol": "CYP2D6*13",
              "name": "*13",
              "version": 37
            },
            "version": 0
          },
          {
            "id": 1451421233,
            "_label": "*14",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166181185",
              "symbol": "CYP2D6*14",
              "name": "*14",
              "version": 15
            },
            "version": 0
          },
          {
            "id": 1451421234,
            "_label": "*15",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971568",
              "symbol": "CYP2D6*15",
              "name": "*15",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421235,
            "_label": "*17",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816583",
              "symbol": "CYP2D6*17",
              "name": "*17",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451421236,
            "_label": "*17x2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166123457",
              "symbol": "CYP2D6*17x2",
              "name": "*17x2",
              "version": 21
            },
            "version": 0
          },
          {
            "id": 1451421237,
            "_label": "*18",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971569",
              "symbol": "CYP2D6*18",
              "name": "*18",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421238,
            "_label": "*19",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971570",
              "symbol": "CYP2D6*19",
              "name": "*19",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421239,
            "_label": "*20",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971571",
              "symbol": "CYP2D6*20",
              "name": "*20",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421240,
            "_label": "*21",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165988484",
              "symbol": "CYP2D6*21",
              "name": "*21",
              "version": 38
            },
            "version": 0
          },
          {
            "id": 1451421241,
            "_label": "*29",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165948318",
              "symbol": "CYP2D6*29",
              "name": "*29",
              "version": 41
            },
            "version": 0
          },
          {
            "id": 1451421242,
            "_label": "*29x2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166128735",
              "symbol": "CYP2D6*29x2",
              "name": "*29x2",
              "version": 14
            },
            "version": 0
          },
          {
            "id": 1451421243,
            "_label": "*31",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971582",
              "symbol": "CYP2D6*31",
              "name": "*31",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421244,
            "_label": "*33",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971584",
              "symbol": "CYP2D6*33",
              "name": "*33",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421245,
            "_label": "*35",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165988487",
              "symbol": "CYP2D6*35",
              "name": "*35",
              "version": 38
            },
            "version": 0
          },
          {
            "id": 1451421260,
            "_label": "*35x2",
            "function": {
              "id": 1451309754,
              "description": "CYP2D6 function",
              "parents": [],
              "resource": "Allele Function",
              "term": "Increased function (AV 2)",
              "termId": "alleleFunction:1451309754",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228166",
              "symbol": "CYP2D6*35x2",
              "name": "*35x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451421246,
            "_label": "*36",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165988488",
              "symbol": "CYP2D6*36",
              "name": "*36",
              "version": 38
            },
            "version": 0
          },
          {
            "id": 1451421261,
            "_label": "*36x2",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166228167",
              "symbol": "CYP2D6*36x2",
              "name": "*36x2",
              "version": 1
            },
            "version": 0
          },
          {
            "id": 1451421247,
            "_label": "*38",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971592",
              "symbol": "CYP2D6*38",
              "name": "*38",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421248,
            "_label": "*39",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166001447",
              "symbol": "CYP2D6*39",
              "name": "*39",
              "version": 38
            },
            "version": 0
          },
          {
            "id": 1451421249,
            "_label": "*40",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971594",
              "symbol": "CYP2D6*40",
              "name": "*40",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421250,
            "_label": "*41",
            "function": {
              "id": 1445558331,
              "parents": [],
              "resource": "Allele Function",
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165816584",
              "symbol": "CYP2D6*41",
              "name": "*41",
              "version": 42
            },
            "version": 0
          },
          {
            "id": 1451421251,
            "_label": "*41x2",
            "function": {
              "id": 1445558335,
              "parents": [],
              "resource": "Allele Function",
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166128209",
              "symbol": "CYP2D6*41x2",
              "name": "*41x2",
              "version": 15
            },
            "version": 0
          },
          {
            "id": 1451421252,
            "_label": "*42",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA165971595",
              "symbol": "CYP2D6*42",
              "name": "*42",
              "version": 39
            },
            "version": 0
          },
          {
            "id": 1451421253,
            "_label": "*114",
            "function": {
              "id": 1445558515,
              "parents": [],
              "resource": "Allele Function",
              "term": "No function",
              "termId": "haplotypeTags:1445558515",
              "version": 1
            },
            "haplotype": {
              "objCls": "Haplotype",
              "id": "PA166181184",
              "symbol": "CYP2D6*114",
              "name": "*114",
              "version": 15
            },
            "version": 0
          }
        ],
        "gene": {
          "objCls": "Gene",
          "id": "PA128",
          "symbol": "CYP2D6",
          "name": "cytochrome P450 family 2 subfamily D member 6",
          "alleleFile": "CYP2D6_allele_definition_table.xlsx",
          "altNames": {
            "synonym": [
              "cytochrome P450, family 2, subfamily D, polypeptide 6"
            ],
            "symbol": [
              "CPD6",
              "CYP2D",
              "CYP2D7AP",
              "CYP2D7BP",
              "CYP2D7P2",
              "CYP2D8P2",
              "CYP2DL1",
              "P450-DB1",
              "P450C2D"
            ]
          },
          "buildVersion": "GRCh38.p7",
          "cbStart": "q13.1",
          "cbStop": "q13.2",
          "chr": {
            "objCls": "Chromosome",
            "id": "PA525",
            "name": "chr22",
            "version": 3
          },
          "chrStartPosB37": 42522501,
          "chrStartPosB38": 42125531,
          "chrStopPosB37": 42526883,
          "chrStopPosB38": 42130881,
          "cpicGene": true,
          "crossReferences": [
            {
              "id": 553242505,
              "resource": "Comparative Toxicogenomics Database",
              "resourceId": "1565",
              "_url": "http://ctdbase.org/detail.go?type=gene&acc=1565",
              "version": 0
            },
            {
              "id": 132256032,
              "resource": "Ensembl",
              "resourceId": "ENSG00000100197",
              "_url": "https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100197",
              "version": 0
            },
            {
              "id": 73375,
              "resource": "GenAtlas",
              "resourceId": "CYP2D6",
              "_url": "http://genatlas.medecine.univ-paris5.fr/fiche.php?symbol=CYP2D6",
              "version": 1
            },
            {
              "id": 1445332056,
              "resource": "GenBank",
              "resourceId": "AY545216.1",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/AY545216.1",
              "version": 0
            },
            {
              "id": 88303,
              "resource": "GeneCard",
              "resourceId": "CYP2D6",
              "_url": "https://www.genecards.org/cgi-bin/carddisp.pl?gene=CYP2D6",
              "version": 1
            },
            {
              "id": 605873023,
              "resource": "HGNC",
              "resourceId": "HGNC:2625",
              "_url": "https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC%3A2625",
              "version": 1
            },
            {
              "id": 605873080,
              "resource": "HumanCyc Gene",
              "resourceId": "HS01997",
              "_url": "http://biocyc.org/HUMAN/NEW-IMAGE?object=HS01997",
              "version": 0
            },
            {
              "id": 560877840,
              "resource": "ModBase",
              "resourceId": "P10635",
              "_url": "http://salilab.org/modbase/search?modelflag=longest&databaseID=P10635",
              "version": 0
            },
            {
              "id": 455913,
              "resource": "MutDB",
              "resourceId": "CYP2D6",
              "_url": "http://www.mutdb.org/genes/search?_method=POST&data%5BSearch%5D%5Bidentifier%5D=CYP2D6",
              "version": 1
            },
            {
              "id": 10749,
              "resource": "NCBI Gene",
              "resourceId": "1565",
              "_url": "https://www.ncbi.nlm.nih.gov/gene/1565",
              "version": 1
            },
            {
              "id": 717,
              "resource": "OMIM",
              "resourceId": "124030",
              "_url": "https://omim.org/entry/124030",
              "version": 1
            },
            {
              "id": 560556323,
              "resource": "OMIM",
              "resourceId": "608902",
              "_url": "https://omim.org/entry/608902",
              "version": 0
            },
            {
              "id": 1451280333,
              "resource": "PharmVar Gene",
              "resourceId": "CYP2D6",
              "_url": "https://www.pharmvar.org/gene/CYP2D6",
              "version": 0
            },
            {
              "id": 1451167850,
              "name": "NG_008376.4",
              "resource": "RefSeq DNA",
              "resourceId": "NG_008376.4",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NG_008376.4",
              "version": 0
            },
            {
              "id": 37278,
              "resource": "RefSeq Protein",
              "resourceId": "NP_000097",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NP_000097",
              "version": 1
            },
            {
              "id": 123170196,
              "resource": "RefSeq Protein",
              "resourceId": "NP_001020332",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NP_001020332",
              "version": 1
            },
            {
              "id": 46353,
              "resource": "RefSeq RNA",
              "resourceId": "NM_000106",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NM_000106",
              "version": 1
            },
            {
              "id": 123170193,
              "resource": "RefSeq RNA",
              "resourceId": "NM_001025161",
              "_url": "https://www.ncbi.nlm.nih.gov/nuccore/NM_001025161",
              "version": 1
            },
            {
              "id": 121670,
              "resource": "UCSC Genome Browser",
              "resourceId": "NM_000106",
              "_url": "https://genome.ucsc.edu/cgi-bin/hgTracks?Submit=Submit&position=NM_000106",
              "version": 1
            },
            {
              "id": 605873078,
              "name": "Q6NWU0_HUMAN",
              "resource": "UniProtKB",
              "resourceId": "Q6NWU0",
              "_url": "https://www.uniprot.org/uniprot/Q6NWU0",
              "version": 1
            },
            {
              "id": 605873076,
              "name": "Q6NXU8_HUMAN",
              "resource": "UniProtKB",
              "resourceId": "Q6NXU8",
              "_url": "https://www.uniprot.org/uniprot/Q6NXU8",
              "version": 1
            }
          ],
          "hasNonStandardHaplotypes": false,
          "hideHaplotypes": false,
          "pharmVarGene": true,
          "strand": "minus",
          "terms": [
            {"id":560498878,"_url":"http://amigo.geneontology.org/amigo/term/GO:0004497","resource":"Gene Ontology","term":"monooxygenase activity","termId":"GO:0004497"},
            {"id":560500079,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005739","resource":"Gene Ontology","term":"mitochondrion","termId":"GO:0005739"},
            {"id":560500134,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005783","resource":"Gene Ontology","term":"endoplasmic reticulum","termId":"GO:0005783"},
            {"id":560500141,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005789","resource":"Gene Ontology","term":"endoplasmic reticulum membrane","termId":"GO:0005789"},
            {"id":560500144,"_url":"http://amigo.geneontology.org/amigo/term/GO:0005792","resource":"Gene Ontology","term":"microsome","termId":"GO:0005792"},
            {"id":560501453,"_url":"http://amigo.geneontology.org/amigo/term/GO:0006805","resource":"Gene Ontology","term":"xenobiotic metabolic process","termId":"GO:0006805"},
            {"id":560499864,"_url":"http://amigo.geneontology.org/amigo/term/GO:0008144","resource":"Gene Ontology","term":"drug binding","termId":"GO:0008144"},
            {"id":560501294,"_url":"http://amigo.geneontology.org/amigo/term/GO:0008202","resource":"Gene Ontology","term":"steroid metabolic process","termId":"GO:0008202"},
            {"id":560503412,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009055","resource":"Gene Ontology","term":"electron carrier activity","termId":"GO:0009055"},
            {"id":560504161,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009804","resource":"Gene Ontology","term":"coumarin metabolic process","termId":"GO:0009804"},
            {"id":560504179,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009820","resource":"Gene Ontology","term":"alkaloid metabolic process","termId":"GO:0009820"},
            {"id":560504180,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009822","resource":"Gene Ontology","term":"alkaloid catabolic process","termId":"GO:0009822"},
            {"id":560504242,"_url":"http://amigo.geneontology.org/amigo/term/GO:0009892","resource":"Gene Ontology","term":"negative regulation of metabolic process","termId":"GO:0009892"},
            {"id":560499972,"_url":"http://amigo.geneontology.org/amigo/term/GO:0016020","resource":"Gene Ontology","term":"membrane","termId":"GO:0016020"},
            {"id":560506711,"_url":"http://amigo.geneontology.org/amigo/term/GO:0016098","resource":"Gene Ontology","term":"monoterpenoid metabolic process","termId":"GO:0016098"},
            {"id":560495264,"_url":"http://amigo.geneontology.org/amigo/term/GO:0016491","resource":"Gene Ontology","term":"oxidoreductase activity","termId":"GO:0016491"},
            {"id":560507281,"_url":"http://amigo.geneontology.org/amigo/term/GO:0017144","resource":"Gene Ontology","term":"drug metabolic process","termId":"GO:0017144"},
            {"id":560509358,"_url":"http://amigo.geneontology.org/amigo/term/GO:0020037","resource":"Gene Ontology","term":"heme binding","termId":"GO:0020037"},
            {"id":560512928,"_url":"http://amigo.geneontology.org/amigo/term/GO:0033076","resource":"Gene Ontology","term":"isoquinoline alkaloid metabolic process","termId":"GO:0033076"},
            {"id":560515689,"_url":"http://amigo.geneontology.org/amigo/term/GO:0042737","resource":"Gene Ontology","term":"drug catabolic process","termId":"GO:0042737"},
            {"id":560495388,"_url":"http://amigo.geneontology.org/amigo/term/GO:0046483","resource":"Gene Ontology","term":"heterocycle metabolic process","termId":"GO:0046483"},
            {"id":560495445,"_url":"http://amigo.geneontology.org/amigo/term/GO:0046872","resource":"Gene Ontology","term":"metal ion binding","termId":"GO:0046872"},
            {"id":560511965,"_url":"http://amigo.geneontology.org/amigo/term/GO:0051100","resource":"Gene Ontology","term":"negative regulation of binding","termId":"GO:0051100"},
            {"id":560509993,"_url":"http://amigo.geneontology.org/amigo/term/GO:0055114","resource":"Gene Ontology","term":"oxidation reduction","termId":"GO:0055114"},
            {"id":560523003,"_url":"http://amigo.geneontology.org/amigo/term/GO:0070330","resource":"Gene Ontology","term":"aromatase activity","termId":"GO:0070330"}
          ],
          "version": 7890
        },
        "version": 0
      }
    ],
    "hasTestingInfo": true,
    "history": [
      {
        "id": 1183704545,
        "date": "2011-08-10T00:00:00-07:00",
        "type": "Create",
        "version": 0
      },
      {
        "id": 1450415065,
        "date": "2019-05-23T15:45:11.757-07:00",
        "description": "Annotation current with November 2018 DPWG Guideline release",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1450820684,
        "date": "2019-10-03T17:08:14.139-07:00",
        "description": "Slight wording changes based on August 2019 guidelines",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1450956521,
        "date": "2020-01-31T14:21:32.927-08:00",
        "description": "Updated link to 2011 DPWG methods",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1450963942,
        "date": "2020-02-11T08:19:44.307-08:00",
        "description": "Fixed links to 2019 guideline pdfs. 2018 link already went to attachment.",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451431307,
        "date": "2021-05-04T00:00:00-07:00",
        "description": "Added extended dosing",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451704209,
        "date": "2022-03-03T16:33:28.275-08:00",
        "description": "Annotation current with May 2021 DPWG Guideline release",
        "type": "Note",
        "version": 0
      },
      {
        "id": 1451707842,
        "date": "2022-03-08T13:05:32.128-08:00",
        "description": "Added information about preemptive genotyping",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451732849,
        "date": "2022-03-28T09:57:41.991-07:00",
        "description": "Annotation current with February 2022 DPWG guideline release",
        "type": "Note",
        "version": 0
      },
      {
        "id": 1451741550,
        "date": "2022-04-05T11:21:29.587-07:00",
        "description": "Added testing guidance tag",
        "type": "Update",
        "version": 0
      },
      {
        "id": 1451884764,
        "date": "2022-09-16T14:50:15.221-07:00",
        "description": "Fixed link to gene information document and added explanatory note",
        "type": "Update",
        "version": 0
      }
    ],
    "literature": [
      {"id":7283333,"title":"Pharmacogenetics: from bench to byte--an update of guidelines.","_sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/21412232","crossReferences":[{"id":769250885,"resource":"PubMed","resourceId":"21412232","_url":"https://www.ncbi.nlm.nih.gov/pubmed/21412232"},{"id":1449247827,"resource":"DOI","resourceId":"10.1038/clpt.2011.34","_url":"http://dx.doi.org/10.1038%2Fclpt.2011.34"}],"objCls":"Literature","terms":[]},
      {"id":15103288,"title":"Dutch Pharmacogenetics Working Group Guidelines August 2019","_sameAs":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf","crossReferences":[{"id":1450815695,"resource":"URL","resourceId":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf","_url":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_August_2019.pdf"}],"objCls":"Literature","terms":[]},
      {"id":15102465,"title":"Dutch Pharmacogenetics Working Group Guidelines November 2018","_sameAs":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf","crossReferences":[{"id":1450415575,"resource":"URL","resourceId":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf","_url":"https://api.pharmgkb.org/v1/preview/download/file/attachment/DPWG_November_2018.pdf"}],"objCls":"Literature","terms":[]}
    ],
    "pediatric": false,
    "recommendation": true,
    "relatedAlleles": [],
    "relatedChemicals": [
      {
        "objCls": "Chemical",
        "id": "PA451866",
        "name": "venlafaxine",
        "version": 6
      }
    ],
    "relatedGenes": [
      {
        "objCls": "Gene",
        "id": "PA128",
        "symbol": "CYP2D6",
        "name": "cytochrome P450 family 2 subfamily D member 6",
        "version": 7890
      }
    ],
    "source": "DPWG",
    "summaryMarkdown": {
      "id": 1447981908,
      "html": "<p>For CYP2D6 poor (PM) and intermediate metabolizers (IM), select an alternative to venlafaxine or reduce the dose and monitor patient's plasma metabolite level. For CYP2D6 ultrarapid metabolizers (UM), increase dose to 150% of the normal dose or select an alternative to venlafaxine.</p>\n",
      "version": 1
    },
    "terms": [],
    "textMarkdown": {
      "id": 1447981907,
      "html": "<h3 id=\"august-2019-update\">August 2019 Update</h3>\n<p><em><strong>IMPORTANT: As of March 2022, gene information documents from the DPWG are no longer publicly available from the KNMP website. PharmGKB is currently providing PDF versions of these documents to users. These files were downloaded in February 2022. As such, we cannot guarantee that these documents match the mappings DPWG may use internally as there have been no publicly accessible updates since February 2022.</strong></em></p>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for venlafaxine based on CYP2D6 genotype. They recommend that an alternative drug that is not metabolized by CYP2D6 or a dose reduction be considered for CYP2D6 intermediate metabolizers (IMs) and poor metabolizers (PMs). Clinicians should be alert to possible decreases in venlafaxine plasma concentrations in CYP2D6 ultrarapid metabolizers (UMs) and, if necessary, increase the dose to 150% of the standard dose. If a dose increase is not possible, an alternative drug that is not metabolized by CYP2D6 should be selected.</p>\n<p><em>Wording in table taken from <a download=\"DPWG_August_2019.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_August_2019.pdf\">Dutch guidelines August 2019 update</a></em></p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Allele/Genotype/Phenotype</th>\n<th>Drug</th>\n<th>Description</th>\n<th>Recommendation</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>CYP2D6 UM</td>\n<td>venlafaxine</td>\n<td>It may be difficult to adjust the dose for patients due to altered metabolism between venlafaxine and the active metabolite O- desmethylvenlafaxine. The gene variation increases the conversion of venlafaxine to O-desmethylvenlafaxine and reduces the sum of venlafaxine plus O-desmethylvenlafaxine.</td>\n<td>1. be alert to a possible decrease in the sum of the plasma concentrations of venlafaxine and the active metabolite O- desmethylvenlafaxine<br/>2. if necessary, increase the dose to 150% of the standard dose<br/>3. if dose adjustment does not result in efficacy without unacceptable side effects or if dose adjustment based on therapeutic drug monitoring is not possible, then venlafaxine should be avoided<br/>Antidepressants that are not metabolised by CYP2D6 - or to a lesser extent - include, for example, duloxetine, mirtazapine, citalopram and sertraline.</td>\n</tr>\n<tr>\n<td>CYP2D6 IM</td>\n<td>venlafaxine</td>\n<td>There are indications of an increased risk of side effects and a reduced chance of efficacy. The gene variation reduces the conversion of venlafaxine to the active metabolite O-desmethylvenlafaxine, whilst an association between high O-desmethylvenlafaxine/venlafaxine ratios and response without side effects was found.</td>\n<td>It is not possible to offer adequately substantiated advice for dose reduction based on the literature.<br/>- avoid venlafaxine. Antidepressants that are not metabolised by CYP2D6 - or to a lesser extent - include, for example, duloxetine, mirtazapine, citalopram and sertraline.<br/>- if it is not possible to avoid venlafaxine and side effects occur:<br/>1. reduce the dose<br/>2. monitor the effect and side effects or check the plasma concentrations of venlafaxine and O-desmethylvenlafaxine.<br/>It is not known whether it is possible to reduce the dose to such an extent that the side effects disappear, while the effectiveness is maintained. In general, it is assumed that the effectiveness is determined by the sum of the plasma concentrations of venlafaxine and O-desmethylvenlafaxine. However, the side effects do not appear to be related to this sum.</td>\n</tr>\n<tr>\n<td>CYP2D6 PM</td>\n<td>venlafaxine</td>\n<td>There are indications of an increased risk of side effects and a reduced chance of efficacy. The gene variation reduces the conversion of venlafaxine to the active metabolite O-desmethylvenlafaxine, whilst an association between high O-desmethylvenlafaxine/venlafaxine ratios and response without side effects was found.</td>\n<td>It is not possible to offer adequately substantiated advice for dose reduction based on the literature.<br/>- avoid venlafaxine.  Antidepressants that are not metabolised by CYP2D6 - or to a lesser extent - include, for example, duloxetine, mirtazapine, citalopram and sertraline.<br/>- If it is not possible to avoid venlafaxine and side effects occur:<br/>1. reduce the dose<br/>2. monitor the effect and side effects or check the plasma concentrations of venlafaxine and O-desmethylvenlafaxine<br/>It is not known whether it is possible to reduce the dose to such an extent that the side effects disappear, while the effectiveness is maintained. In general, it is assumed that the effectiveness is determined by the sum of the plasma concentrations of venlafaxine and O-desmethylvenlafaxine. However, the side effects do not appear to be related to this sum. Furthermore, a reduced effectiveness of venlafaxine has been observed in depression patients with this gene variation.</td>\n</tr>\n</tbody>\n</table>\n<h4 id=\"preemptive-genotyping\">Preemptive genotyping</h4>\n<p>Excerpts from the <a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0001539.PDF\" target=\"_blank\">DPWG risk analysis document</a> for venlafaxine and CYP2D6:</p>\n<blockquote class=\"blockquote\">\n<p>The Dutch Pharmacogenetics Working Group considers genotyping before starting venlafaxine to be potentially beneficial for drug efficacy and prevention of adverse events. Genotyping can be considered on an individual patient basis. If, however, the genotype is available, the Dutch Pharmacogenetics Working Group recommends adhering to the gene-drug guideline.</p>\n</blockquote>\n<p><a href=\"/page/dpwgPreemptiveGenotyping\">Read more about how DPWG assigns their recommendations for preemptive genotyping.</a></p>\n<p><a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0001539.PDF\" target=\"_blank\">Read for more information about this recommendation</a>, <a download=\"CYP2D6.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/CYP2D6.pdf\">Read about gene information from DPWG</a></p>\n<h3 id=\"november-2018-update\">November 2018 Update</h3>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for venlafaxine based on CYP2D6 genotype. They recommend that an alternative drug that is not metabolized by CYP2D6 or a dose reduction be considered for CYP2D6 intermediate metabolizers (IMs) and poor metabolizers (PMs). Clinicians should be alert to possible decreases in venlafaxine plasma concentrations in CYP2D6 ultrarapid metabolizers (UMs) and, if necessary, increase the dose to 150% of the standard dose. If a dose increase is not possible, an alternative drug that is not metabolized by CYP2D6 should be selected.</p>\n<p><em>Wording in table taken from the <a download=\"DPWG_November_2018.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_November_2018.pdf\">Dutch guidelines November 2018 update</a>.</em></p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Allele/Genotype/Phenotype</th>\n<th>Drug</th>\n<th>Description</th>\n<th>Recommendation</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>CYP2D6 UM</td>\n<td>venlafaxine</td>\n<td>The genetic polymorphism leads to increased metabolic capacity of CYP2D6. This can cause a decrease in the plasma concentration of venlafaxine and an increase in the plasma concentration of the active metabolite O-desmethylvenlafaxine.</td>\n<td>Recommendation:<br/>1. be alert to a possible decrease in the sum of the plasma concentrations of venlafaxine and the active metabolite O-desmethylvenlafaxine<br/>2. if necessary, increase the dose to 150% of the standard dose<br/>3. if dose adjustment based on therapeutic drug monitoring is not possible, an alternative should be selected. Antidepressants that are not metabolised by CYP2D6 - or to a lesser extent - include, for example, citalopram and sertraline.</td>\n</tr>\n<tr>\n<td>CYP2D6 IM</td>\n<td>venlafaxine</td>\n<td>The genetic polymorphism leads to decreased metabolic capacity of CYP2D6. This can cause an increase in the plasma concentration of venlafaxine and a decrease in the plasma concentration of the active metabolite O-desmethylvenlafaxine.</td>\n<td>It is not possible to offer adequately substantiated advice for dose reduction based on the literature.<br/>1. Choose an alternative. Antidepressants that are not metabolised by CYP2D6 - or to a lesser extent - include, for example, citalopram and sertraline.<br/>2. If an alternative is not an option and side effects occur:<br/>a. reduce the dose<br/>b. check the plasma concentrations of venlafaxine and O-desmethylvenlafaxine. It is not known whether it is possible to reduce the dose to such an extent that the side effects disappear, while the effectiveness is maintained. In general, it is assumed that the effectiveness is determined by the sum of the plasma concentrations of venlafaxine and O-desmethylvenlafaxine. However, the side effects do not appear to be related to this sum.</td>\n</tr>\n<tr>\n<td>CYP2D6 PM</td>\n<td>venlafaxine</td>\n<td>The genetic polymorphism leads to decreased metabolic capacity of CYP2D6. This can cause an increase in the plasma concentration of venlafaxine and a decrease in the plasma concentration of the active metabolite O-desmethylvenlafaxine. There are indications that the effectiveness of venlafaxine is reduced in depression patients with this genetic polymorphism.</td>\n<td>It is not possible to offer adequately substantiated advice for dose reduction based on the literature.<br/>1. Choose an alternative. Antidepressants that are not metabolised by CYP2D6 - or to a lesser extent - include, for example, citalopram and sertraline.<br/>2. If an alternative is not an option and side effects occur:<br/>a. reduce the dose<br/>b. check the plasma concentrations of venlafaxine and O-desmethylvenlafaxine. It is not known whether it is possible to reduce the dose to such an extent that the side effects disappear, while the effectiveness is maintained. In general, it is assumed that the effectiveness is determined by the sum of the plasma concentrations of venlafaxine and O-desmethylvenlafaxine. However, the side effects do not appear to be related to this sum. Furthermore, a reduced effectiveness of venlafaxine has been observed in depression patients with this genetic polymorphism.</td>\n</tr>\n</tbody>\n</table>\n<p><a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0001539.PDF\" target=\"_blank\">Read for more information about this recommendation</a>, <a rel=\"noopener noreferrer\" href=\"https://www.knmp.nl/producten/gebruiksrecht-g-standaard/medicatiebewaking-g-standaard/background-information-pharmacogenetics\" target=\"_blank\">Read about gene information from DPWG</a></p>\n<h3 id=\"2011-guideline\">2011 Guideline</h3>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for venlafaxine based on CYP2D6 genotypes [Article:<a href=\"/pmid/21412232\">21412232</a>].  For PM and IM genotypes, they state that there are not sufficient data to allow calculation of dose adjustment, and they recommend selecting an alternative drug or adjusting dose to clinical response and monitoring (O-desmethyl)venlafaxine plasma concentration.  For UM genotypes, they recommend titrating dose to a maximum of 150% of the normal dose(based on venlafaxine and (O-desmethyl)venlafaxine plasma concentration) or selecting an alternative drug.</p>\n<table class=\"table\">\n<thead>\n<tr>\n<th>Phenotype (Genotype)</th>\n<th>Therapeutic Dose Recommendation</th>\n<th>Level of Evidence</th>\n<th>Clinical Relevance</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>PM (two inactive (*3-*8, *11-*16, *19-*21, *38, *40, *42) alleles)</td>\n<td>Insufficient data to allow calculation of dose adjustment.  Select alternative drug (e.g., citalopram, sertraline) or adjust dose to clinical response and monitor (O-desmethyl)venlafaxine plasma concentration.</td>\n<td>Published controlled studies of good quality* relating to phenotyped and/or genotyped patients or healthy volunteers, and having relevant pharmacokinetic or clinical endpoints.</td>\n<td>Clinical effect (S): long-standing discomfort (48-168 hr) without permanent injury e.g. failure of therapy with tricyclic antidepressants, atypical antipsychotic drugs; extrapyramidal side effects; parkinsonism; ADE resulting from increased bioavailability of tricyclic antidepressants, metoprolol, propafenone (central effects e.g. dizziness); INR 4.5-6.0; neutropenia 1.0-1.5x10<sup>9</sup>/l; leucopenia 2.0-3.0x10<sup>9</sup>/l; thrombocytopenia 50-75x10<sup>9</sup>/l.</td>\n</tr>\n<tr>\n<td>IM (two decreased-activity (*9, *10, *17, *29, *36, *41) alleles or carrying one active (*1, *2, *33, *35) and one inactive (*3-*8, *11-*16, *19-*21, *38, *40, *42) allele, or carrying one decreased-activity (*9, *10, *17, *29, *36, *41) allele and one inactive (*3-*8, *11-*16, *19-*21, *38, *40, *42) allele)</td>\n<td>Insufficient data to allow calculation of dose adjustment.  Select alternative drug (e.g., citalopram, sertraline) or adjust dose to clinical response and monitor (O-desmethyl)venlafaxine plasma concentration.</td>\n<td>Published controlled studies of good quality* relating to phenotyped and/or genotyped patients or healthy volunteers, and having relevant pharmacokinetic or clinical endpoints.</td>\n<td>Clinical effect (S): long-standing discomfort (48-168 hr) without permanent injury e.g. failure of therapy with tricyclic antidepressants, atypical antipsychotic drugs; extrapyramidal side effects; parkinsonism; ADE resulting from increased bioavailability of tricyclic antidepressants, metoprolol, propafenone (central effects e.g. dizziness); INR 4.5-6.0; neutropenia 1.0-1.5x10<sup>9</sup>/l; leucopenia 2.0-3.0x10<sup>9</sup>/l; thrombocytopenia 50-75x10<sup>9</sup>/l.</td>\n</tr>\n<tr>\n<td>UM (a gene duplication in absence of inactive (*3-*8, *11-*16, *19-*21, *38, *40, *42) or decreased-activity (*9, *10, *17, *29, *36, *41) alleles)</td>\n<td>Be alert to decreased venlafaxine and increased (O-desmethyl)venlafaxine plasma concentration. Titrate dose to a maximum of 150% of the normal dose or select alternative drug (e.g., citalopram, sertraline).</td>\n<td>Published controlled studies of good quality* relating to phenotyped and/or genotyped patients or healthy volunteers, and having relevant pharmacokinetic or clinical endpoints.</td>\n<td>Minor clinical effect (S): QTc prolongation (&lt;450 ms female, &lt;470 ms male); INR increase &lt; 4.5.  Kinetic effect (S).</td>\n</tr>\n</tbody>\n</table>\n<ul>\n<li>*See <a href=\"http://www.pharmgkb.org/page/dpwg\">Methods </a> or [Article:<a href=\"/pmid/18253145\">18253145</a>] for definition of &quot;good quality.&quot;</li>\n<li>S: statistically significant difference.</li>\n<li>Please see attached PDF for detailed information about the evaluated studies: <a download=\"venlafaxine_CYP2D6_271111.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/venlafaxine_CYP2D6_271111.pdf\">Venlafaxine CYP2D6</a></li>\n</ul>\n",
      "version": 14
    },
    "userId": "cfthorn",
    "version": 27
  }
}